With the advent of new technologies and the implementation of pharmacogenetic testing, there is a greater emphasis on pairing therapeutic response and toxicity to the appropriate population subsets. Ambry Genetics is well positioned to help researchers meet this goal. Our GLP-compliant and CLIA-approved laboratory can help you meet your clinical trial needs.  From basic drug metabolism studies to full genotyping, Ambry has the experience and the expertise to help you reach your project goals. Our team of MD and PhD scientists are always available to assist with free consultations or explanation of results.